These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 604659)

  • 21. Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):161-72. PubMed ID: 1522358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trial with clofazimine in leprosy.
    Ganapati R; Dongre VV
    Lepr India; 1976 Oct; 48(4 Suppl):703-8. PubMed ID: 1026807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug therapy for treatment of paucibacillary leprosy in western Kenya--preliminary communications.
    Orege PA; Obura M; Okelo C; Okuku P; Makokha S; Nyawalo J
    East Afr Med J; 1990 Sep; 67(9):632-9. PubMed ID: 2253572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic disposition of dapsone in patients with dapsone-resistant leprosy.
    Peters JH; Gordon GR; Levy L; Strokan MA; Jacobson RR; Enna CD; Kirchheimer WF
    Am J Trop Med Hyg; 1974 Mar; 23(2):222-30. PubMed ID: 4817667
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].
    Constant-Desportes-Relouzat M; Grosset J; Guelpalauras CC; Salvini B; Cales-Quist D
    Acta Leprol; 1986; 4(3):293-300. PubMed ID: 3551468
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Dapsone dosage and drug resistance.
    Pfaltzgraff RE
    Lepr Rev; 1975 Sep; 46(3):235-8. PubMed ID: 1186417
    [No Abstract]   [Full Text] [Related]  

  • 27. Intramuscular injection of dapsone in therapy for leprosy: a new approach.
    Modderman ES; Huikeshoven H; Zuidema J; Leiker DL; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):51-6. PubMed ID: 7061179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 29. Clofazimine and dapsone--a combination therapy in erythema nodosum leprosum syndrome.
    Dutta RK
    Lepr India; 1980 Apr; 52(2):252-9. PubMed ID: 7453140
    [No Abstract]   [Full Text] [Related]  

  • 30. DDS chemoprophylaxis for leprosy in children at Culion Sanitarium Palawan, Philippines.
    Lara CB
    Acta Leprol; 1978; (70):35-58. PubMed ID: 104537
    [No Abstract]   [Full Text] [Related]  

  • 31. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract]   [Full Text] [Related]  

  • 32. Investigations into the haemolytic effects of dapsone therapy in leprosy patients.
    Balakrishnan S; Karthikeyan S; Ramu G
    Indian J Lepr; 1989 Jan; 61(1):10-6. PubMed ID: 2703739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malaria, leprosy and dapsone.
    Saha K; Kapoor L; Arora VM; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):501-4. PubMed ID: 15115119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of different drug compliance tests available in leprosy.
    Naik SS; Sahasrabudhe RV
    Indian J Lepr; 1988 Apr; 60(2):270-6. PubMed ID: 3192977
    [No Abstract]   [Full Text] [Related]  

  • 35. Multidrug therapy in paucibacillary leprosy--a five year experience.
    Grugni A; Nadkarni NJ; Kini MS
    Indian J Lepr; 1988 Oct; 60(4):589-92. PubMed ID: 3253339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of aspirin and chloramphenicol in normal and leprotic patients before and after dapsone therapy.
    Garg SK; Kumar B; Shukla VK; Bakaya V; Lal R; Kaur S
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):204-5. PubMed ID: 3403099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in the absorption of dapsone after intramuscular injection.
    Modderman ES; Merkus FW; Zuidema J; Hilbers HW; Warndorff T
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):359-65. PubMed ID: 6685698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance.
    Pearson JM; Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115
    [No Abstract]   [Full Text] [Related]  

  • 39. [Supervised bimonthly quadruple chemotherapy in 72 paucibacillary leprosy patients in French Guyana].
    Jamet P; Robin Y
    Acta Leprol; 1988; 6(1):35-44. PubMed ID: 3051853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Operational study to monitor the regularity of dapsone intake by leprosy out-patients.
    Kumar A; Balakrishnan S
    Lepr India; 1983 Jul; 55(3):521-7. PubMed ID: 6656209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.